Xylem Inc.
XYL
$122.85
-$0.46-0.37%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.60B | 8.56B | 8.42B | 8.40B | 7.95B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.60B | 8.56B | 8.42B | 8.40B | 7.95B |
| Cost of Revenue | 5.37B | 5.35B | 5.31B | 5.31B | 5.03B |
| Gross Profit | 3.23B | 3.21B | 3.11B | 3.09B | 2.92B |
| SG&A Expenses | 1.85B | 1.86B | 1.74B | 1.78B | 1.74B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.44B | 7.44B | 7.28B | 7.33B | 7.01B |
| Operating Income | 1.15B | 1.12B | 1.14B | 1.07B | 941.00M |
| Income Before Tax | 1.11B | 1.09B | 922.00M | 838.00M | 705.00M |
| Income Tax Expenses | 204.00M | 197.00M | 92.00M | 73.00M | 42.00M |
| Earnings from Continuing Operations | 904.00 | 890.00 | 830.00 | 765.00 | 663.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.00M | -- | -- | -- | -- |
| Net Income | 906.00M | 890.00M | 830.00M | 765.00M | 663.00M |
| EBIT | 1.15B | 1.12B | 1.14B | 1.07B | 941.00M |
| EBITDA | 1.73B | 1.68B | 1.70B | 1.63B | 1.45B |
| EPS Basic | 3.73 | 3.67 | 3.43 | 3.17 | 2.81 |
| Normalized Basic EPS | 2.92 | 2.82 | 2.89 | 2.72 | 2.45 |
| EPS Diluted | 3.71 | 3.65 | 3.42 | 3.16 | 2.81 |
| Normalized Diluted EPS | 2.91 | 2.80 | 2.88 | 2.70 | 2.44 |
| Average Basic Shares Outstanding | 971.58M | 970.33M | 968.60M | 966.54M | 929.51M |
| Average Diluted Shares Outstanding | 974.84M | 974.08M | 972.78M | 971.22M | 934.42M |
| Dividend Per Share | 1.48 | 1.44 | 1.41 | 1.38 | 1.35 |
| Payout Ratio | 39.74% | 39.33% | 41.33% | 43.79% | 49.32% |